000			02198cam a2200349 a 4500
003			EG-GiCUC
005			20250223032336.0
008			190727s2018 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.18.M.Sc.2018.Mo.A
100	0		_aMona Mustafa Kamal Mahmoud
245	1	4	_aThe association between PCSK-9 and cardiovascular complications in patients with type 2 diabetes mellitus / _cMona Mustafa Kamal Mahmoud ; Supervised Amr Abdelhady Elmeligi , Olfat Gameel Shaker , Hala Mohamed Ali
246	1	5	_aوأمراض القلب والأوعية الدموية فى مرضى الداء السكرى من النوع الثانى (PCSK9) العلاقه بين مستوى الدم
260			_aCairo : _bMona Mustafa Kamal Mahmoud , _c2018
300			_a131 P. : _bcharts , facimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
520			_aOur study was carried out to evaluate the circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in patients with T2 diabetes and its relationship to other CVD risk factors,We included 50 patients with DM (25 males and 25 females) and 30 persons as control (15 males and 15 females), Participants age (40-60) without H/O:ASD,lipid lowering treatment,cancers or pregnancy, All participants underwent comprehensive history taking and physical examination, BP, cardiovascular system examination , body mass index (BMI) and waist circumference (WC) and resting ECG. For all the participants we did:FBS,HbA1C, Serum creatinine, estimated GFR using Cockcroft equation, Cholesterol,TG, HDLc,LDL cholesterol(assay)& Serum PCSK9 levels ( measured by ELISA)
530			_aIssued also as CD
653		4	_aCardiovascular disease
653		4	_aPCSK9
653		4	_aType 2 diabetes
700	0		_aAmr Abdelhady Elmeligi , _eSupervisor
700	0		_aHala Mohamed Ali , _eSupervisor
700	0		_aOlfat Gameel Shaker , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c73120 _d73120